Vernolide B is primarily studied for its potential anti-inflammatory and anticancer properties. It has shown activity in inhibiting certain signaling pathways involved in tumor growth, particularly in breast and liver cancer cell lines. Research indicates it may induce apoptosis and suppress cell proliferation, making it a candidate for further investigation in cancer therapy. Additionally, its anti-inflammatory effects suggest possible use in managing chronic inflammatory conditions. Most applications remain in the preclinical research stage, with ongoing studies to evaluate efficacy and safety.